NFKB1 and cystic fibrosis: While it remains uncertain which of the mentioned mechanisms are pre-dominant, WA shows promise as a therapeutic intervention in diseases with chronically elevated levels of NF-κB levels such as Alzheimer [48], diabetes [36] and cystic fibrosis [35].